Researching more than what meets the eye

Consult with our experts

With over 20 years’ experience as a Preclinical CRO, CBI has a range of ocular efficacy and pharmacology studies suitable for your unique research needs.

  • STZ-induced diabetic retinopathy
  • Angiotensin-II retinal vascular leakage
  • Neovascular and vascular models
  • Dry eye models
  • Glaucoma
    • Laser-induced
    • Corticosteroid-induced
    • Water loading
    • Surgically induced
  • Ocular inflammation models
  • Melanin-associated antigen induced anterior uveitis
  • Ocular pain modeling
  • Corneal abrasion
  • VEGF-induced retinal vascular leakage

Our full service in vivo  facility also offers:

  • On-site histopathology lab
  • In-house board-certified pathologist
  • Efficient, quality reporting
  • Immunohistochemistry
  • Angiograms
  • Electroretinogram (ERG)
  • Flow cytometry
  • Fundoscopy
  • Slit lamp exam (SLE)
  • Toxicity assessments
  • Full range of species

Extensive experience with

  • Small molecules
  • Biologics
  • Immunotherapy
  • Stem cells
  • Devices and implants
  • Gene therapy

Standards of excellence

  • GLP equipped
  • AAALAC accredited
  • USDA, FDA and OLAW compliant

Consult with our experts

Fill out the form below to access our white paper on STZ-induced diabetic retinopathy models